Published in Neurosci Lett on May 14, 1993
Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo 1H NMR spectroscopy. J Neurochem (2007) 1.38
Localization of glycine receptors in the human forebrain, brainstem, and cervical spinal cord: an immunohistochemical review. Front Mol Neurosci (2009) 1.04
Low anaerobic threshold and increased skeletal muscle lactate production in subjects with Huntington's disease. Mov Disord (2010) 0.84
Probing the metabolic aberrations underlying mutant huntingtin toxicity in yeast and assessing their degree of preservation in humans and mice. J Proteome Res (2010) 0.81
Rapid etiological classification of meningitis by NMR spectroscopy based on metabolite profiles and host response. PLoS One (2009) 0.80
Metabolic counterpart of decreased apparent diffusion coefficient during hyperacute ischemic stroke: a brain proton magnetic resonance spectroscopic imaging study. Stroke (2003) 1.74
In vivo and in vitro characterization of skeletal muscle metabolism in patients with statin-induced adverse effects. Arthritis Rheum (2006) 1.55
31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology (1992) 1.47
Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia. Acta Anaesthesiol Scand (2004) 1.43
Metabolic events with spontaneous malignant hyperthermia crisis in an anaesthetized pig. Can J Anaesth (1997) 1.40
Dopamine receptors--physiological understanding to therapeutic intervention potential. Pharmacol Ther (1999) 1.38
Detection of new temperature-dependent conformational transition in lysozyme by carbon-13 nuclear magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (1975) 1.34
Phosphorus-31 Fourier transform nuclear magnetic resonance study of mononucleotides and dinucleotides. 1. Chemical shifts. Biochemistry (1976) 1.29
Interrelations of ATP synthesis and proton handling in ischaemically exercising human forearm muscle studied by 31P magnetic resonance spectroscopy. J Physiol (2001) 1.29
31P magnetic resonance spectroscopy study of phosphocreatine recovery kinetics in skeletal muscle: the issue of intersubject variability. Biochim Biophys Acta (2000) 1.19
What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? J Neurol (1994) 1.11
Quantitation of metabolites in human blood serum by proton magnetic resonance spectroscopy. A comparative study of the use of formate and TSP as concentration standards. NMR Biomed (1993) 1.11
MR imaging of epidermoid cysts. Neuroradiology (1987) 1.07
Phosphorus-31 Fourier transform nuclear magnetic resonance study of mononucleotides and dinucleotides. 2. Coupling constants. Biochemistry (1976) 1.06
Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites. Biol Psychiatry (1988) 1.05
Cine-MRI assessment of cardiac function in mice anesthetized with ketamine/xylazine and isoflurane. MAGMA (2004) 1.04
Experimental protocol for clinical analysis of cerebrospinal fluid by high resolution proton magnetic resonance spectroscopy. Brain Res Brain Res Protoc (1998) 1.02
Brain proton magnetic resonance spectroscopy in HIV-related encephalopathy: identification of evolving metabolic patterns in relation to dementia and therapy. AIDS Res Hum Retroviruses (1997) 1.00
Functional investigations of exercising muscle: a noninvasive magnetic resonance spectroscopy-magnetic resonance imaging approach. Cell Mol Life Sci (2004) 0.97
Optimization of residual water signal removal by HLSVD on simulated short echo time proton MR spectra of the human brain. J Magn Reson (2001) 0.97
Modulation of effective connectivity inside the working memory network in patients at the earliest stage of multiple sclerosis. Neuroimage (2004) 0.96
Citrulline/malate promotes aerobic energy production in human exercising muscle. Br J Sports Med (2002) 0.96
A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases. J Neurol Sci (1993) 0.95
Mechanisms of regulation of neurotensin receptors. Pharmacol Ther (1998) 0.95
Lithium compared to valproic acid and carbamazepine in the treatment of mania: a statistical meta-analysis. Eur Neuropsychopharmacol (1996) 0.93
Functional MRI study of PASAT in normal subjects. MAGMA (2005) 0.93
Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet (1995) 0.93
Impact of genomics on drug discovery and clinical medicine. QJM (2000) 0.93
Absence of mutation in the beta-amyloid cDNAs cloned from the brains of three patients with sporadic Alzheimer's disease. Brain Res (1988) 0.93
Brain anomalies in maternally inherited diabetes and deafness syndrome. J Neurol (2009) 0.93
A multicenter proton magnetic resonance spectroscopy study of neurological complications of AIDS. AIDS Res Hum Retroviruses (1996) 0.92
Diffusion-weighted imaging in normal fetal brain maturation. Eur Radiol (2007) 0.92
A noninvasive investigation of muscle energetics supports similarities between exertional heat stroke and malignant hyperthermia. Anesth Analg (2001) 0.92
Analysis of plasma lipids by NMR spectroscopy: application to modifications induced by malignant tumors. J Lipid Res (1993) 0.92
Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis? AJNR Am J Neuroradiol (2012) 0.92
Prospects for pharmacological intervention in Alzheimer disease. Arch Neurol (2000) 0.91
Metabolic profiling in multiple sclerosis and other disorders by quantitative analysis of cerebrospinal fluid using nuclear magnetic resonance spectroscopy. Curr Pharm Biotechnol (2011) 0.91
Phosphorus-31 nuclear-magnetic-resonance study of phosphorylated metabolites compartmentation, intracellular pH and phosphorylation state during normoxia, hypoxia and ethanol perfusion, in the perfused rat liver. Eur J Biochem (1987) 0.91
NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides. Brain Res (1993) 0.91
Amino acid sequence and disulfide bridges of subunit III, a defective endopeptidase present in the bovine pancreatic 6 S procarboxypeptidase A complex. Eur J Biochem (1986) 0.90
Phospholipase C activation by neurotensin and neuromedin N in Chinese hamster ovary cells expressing the rat neurotensin receptor. Brain Res Mol Brain Res (1992) 0.90
Heterogeneity of metabolic response to muscular exercise in humans. New criteria of invariance defined by in vivo phosphorus-31 NMR spectroscopy. FEBS Lett (1990) 0.89
Intracellular sodium increase and susceptibility to ischaemia in hearts from type 2 diabetic db/db mice. Diabetologia (2006) 0.89
Glutamate-glutamine metabolism in the perfused rat liver. 13C-NMR study using (2-13C)-enriched acetate. FEBS Lett (1985) 0.89
Alzheimer disease: mouse models pave the way for therapeutic opportunities. Arch Neurol (2000) 0.89
Segmentation of fascias, fat and muscle from magnetic resonance images in humans: the DISPIMAG software. MAGMA (2006) 0.89
Hepatic metabolism during acute ethanol administration: a phosphorus-31 nuclear magnetic resonance study on the perfused rat liver under normoxic or hypoxic conditions. Hepatology (1987) 0.89
L-arginine during long-term ischemia: effects on cardiac function, energetic metabolism and endothelial damage. J Heart Lung Transplant (2000) 0.89
Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis--a two-year longitudinal MRI/MRSI study of corpus callosum. Mult Scler (2007) 0.87
Efficiency of cognitive control recruitment in the very early stage of multiple sclerosis: a one-year fMRI follow-up study. Mult Scler (2008) 0.86
Gender modulates the energy cost of muscle contraction in untrained healthy subjects. A 31P magnetic resonance spectroscopy analysis. FEBS Lett (1999) 0.86
Cerebrospinal fluid metabolic profiles in multiple sclerosis and degenerative dementias obtained by high resolution proton magnetic resonance spectroscopy. C R Acad Sci III (1996) 0.86
Real-time continuous-flow spin trapping of hydroxyl free radical in the ischemic and post-ischemic myocardium. Eur J Biochem (1989) 0.85
Magnetic resonance spectroscopy of serum and acute-phase proteins revisited: a multiparametric statistical analysis of metabolite variations in inflammatory, infectious and miscellaneous diseases. Clin Chim Acta (1999) 0.85
What is the significance of interictal water diffusion changes in frontal lobe epilepsies? Neuroimage (2007) 0.85
Profile of memory impairment and gray matter loss in amnestic mild cognitive impairment. Neuropsychologia (2007) 0.85
Localized proton magnetic resonance spectroscopy of the brain in children infected with human immunodeficiency virus with and without encephalopathy. Pediatr Res (1998) 0.85
Infratentorial pediatric brain tumors: the value of new imaging modalities. J Neuroradiol (2007) 0.85
Pathological findings in 165 patients explored for malignant hyperthermia susceptibility. Neuromuscul Disord (1994) 0.85
1H-MRS imaging in intractable frontal lobe epilepsies characterized by depth electrode recording. Neuroimage (2005) 0.85
Brain glucose utilization in band heterotopia: synaptic activity of "double cortex". Pediatr Neurol (1994) 0.85
The dose-response relationship in phase I clinical trials and beyond: use, meaning, and assessment. Pharmacol Ther (2000) 0.85
Value of Doppler echocardiography in the detection of low-grade rejections after cardiac transplantation. Transpl Int (1996) 0.85